Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series-Reference-Cited by-同舟云学术

Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series

Published:2022-06 Issue:6 Volume:4 Page:100470
ISSN:2590-0595
Container-title:Kidney Medicine
language:en
Short-container-title:Kidney Medicine

Author:

Fernandes Guillaume,Devresse Arnaud,Scohy Anais,De Greef Julien,Yombi Jean Cyr,Belkhir Leila,Darius Tom,Mourad Michel,Buemi Antoine,Kabamba Benoit,Goffin Eric,Kanaan Nada

Publisher

Elsevier BV

Subject

Nephrology,Internal Medicine

Reference30 articles.

1. Factors associated with COVID-19-related death using OpenSAFELY;Williamson;Nature,2020

2. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe;Jager;Kidney Int,2020

4. Outcomes of COVID-19 in solid organ transplant recipients: a propensity-matched analysis of a large research network;Hadi;Transplantation,2021

5. Immunosuppression and SARS-CoV-2 infection in kidney transplant recipients;Devresse;Transplant Direct,2022

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical practice guideline supported administration of monoclonal antibody therapy for high-risk patients with COVID-19: Experience of a quaternary care centre;Journal of the Association of Medical Microbiology and Infectious Disease Canada;2024-09-10

2. Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort study;Journal of Nephrology;2024-05-23

3. Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19;Frontiers in Medicine;2024-04-03

4. Sotrovimab in solid organ transplant recipients with COVID-19: a systematic review and meta-analysis;Korean Journal of Transplantation;2023-11-03

5. Vaccines and therapeutics for immunocompromised patients with COVID-19;eClinicalMedicine;2023-05